Position in QGEN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$351
-$9 QoQ
Shares Held
9
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#322
of 332 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cullen/Frost Bankers, Inc. holds $46,695,964 across 16 Diagnostics & Research names. QGEN ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
119,584 | $22,778,360 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
41,677 | $20,895,180 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
3,675 | $1,934,667 | |
| 4 | WAT |
Waters Corp /De/
|
766 | $287,280 | |
| 5 | LH |
Labcorp Holdings Inc.
|
711 | $199,080 | |
| 6 | A |
Agilent Technologies, Inc.
|
1,158 | $153,817 | |
| 7 | ILMN |
Illumina, Inc.
|
815 | $143,301 | |
| 8 | RDNT |
RadNet, Inc.
|
2,300 | $141,841 |
All Filings in QGEN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $351 | 9 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $360 | 9 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $43,845 | 975 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $40,256 | 901 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $57,287 | 1,192 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $361 | 9 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $445 | 10 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $455 | 10 | Shares | Defined | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||